APA (7th ed.) Citation

Rojas, A., Sposetti, G., Gross, J. L., Barbieri, D. E., Duan, R., Linetzky, B., . . . Rodriguez, A. (2016). Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial. Diabetology & Metabolic Syndrome, 8, 1. https://doi.org/10.1186/s13098-016-0163-3

Chicago Style (17th ed.) Citation

Rojas, Arturo, Georgina Sposetti, Jorge L. Gross, Douglas Eugenio Barbieri, Ran Duan, Bruno Linetzky, Janaina Martins De Lana, Oded Stempa, and Angel Rodriguez. "Insulin Lispro Low Mixture Twice Daily Vs Basal Insulin Glargine Once Daily and Prandial Insulin Lispro Once Daily as Insulin Intensification Strategies in Patients with Type 2 Diabetes: Latin American Subpopulation Analysis of a Randomized Trial." Diabetology & Metabolic Syndrome 8 (2016): 1. https://doi.org/10.1186/s13098-016-0163-3.

MLA (9th ed.) Citation

Rojas, Arturo, et al. "Insulin Lispro Low Mixture Twice Daily Vs Basal Insulin Glargine Once Daily and Prandial Insulin Lispro Once Daily as Insulin Intensification Strategies in Patients with Type 2 Diabetes: Latin American Subpopulation Analysis of a Randomized Trial." Diabetology & Metabolic Syndrome, vol. 8, 2016, p. 1, https://doi.org/10.1186/s13098-016-0163-3.